Extended vs standard lymph node resection: Overall survival (3‐year
It is very uncertain whether extended changes overall survival (3‐year compared with standard lymph node resection (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Extended vs standard lymph node resection Overall survival (3‐year · people with pancreatic and periampullary adenocarcinoma It is very uncertain whether extended changes overall survival (3‐year compared with standard lymph node resection (very low certainty). Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma (2021) · Cochrane Headline outcomes only | HR 0.12 | 7 studies · 823 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.